The Meakins-Christie Laboratories is one of the premiere centres for pulmonary research in the world and Canada. The Meakins was founded in 1972 by Dr. Peter Macklem. It comprises the largest group of investigators within the Translational Research in Respiratory Diseases Program at the RI-MUHC. Our overall mission is to better understand the pathobiology of respiratory disorders. Our goal is to drive innovations in respiratory disease prevention, diagnosis, and therapy. As a result, our research is focused around four main themes: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
In the News
COVID-19 Special RESP Lab Measures
All Meakins / RESP Program students, fellows, and staff are to follow these special measures during the lab closure
Quebec COVID-19 Biobank
The FRQ is supporting a province-wide COVID-19 biobank. Dr. Simon Rousseau is representing the QRHN.
Stepping up to COVID-19
Stepping up to COVID-19 is an opinion piece written by Dr. Faiz Ahmad Khan, appearing in The Hill Times on March 25, 2020.
COVID-19 Funding Opportunities
COVID-19 funding opportunities for the research community. Updates will be posted on our FO page.
Meakins alumnus modifies ventilator
Dr. Alain Gauthier is a Meakins-Christie alumnus who modified a ventilator during the COVID19 pandemic
Code Life Ventilator Challenge
The MGH Foundation and the RI-MUHC launch the Code Life Ventilator Challenge. Applications due March 31
Upcoming Events
Innate Immune Memory
Registration and abstract submission is open for the International Conference on Innate Immune Memory
Lipid Biology in Respiratory Diseases
NOTE: The Lipid Biology in Respiratory Diseases Workshop is POSTPONED.
